Evaluation of the fibrin stabilizing factor in human platelets: its content in normal thrombocytes and in platelets with functional defects.
D000641:Ammonia / Q000032:analysis; D001772:Blood Cell Count; D001777:Blood Coagulation; D001792:Blood Platelets / Q000032:analysis*; D001798:Blood Proteins / Q000378:metabolism; D005176:Factor XIII / Q000032:analysis* / Q000378:metabolism; D005177:Factor XIII Deficiency / Q000097:blood*; D005337:Fibrin / Q000032:analysis; D005341:Fibrinolysin / Q000494:pharmacology; D005342:Fibrinolysis / Q000187:drug effects; D006801:Humans; D006942:Hypergammaglobulinemia / Q000097:blood; D007106:Immune Sera; D008722:Methods; D011700:Putrescine / Q000378:metabolism; D012995:Solubility; D013300:Streptokinase / Q000494:pharmacology; D013921:Thrombocytopenia / Q000097:blood; D013924:Thrombophlebitis / Q000097:blood; D013997:Time Factors; D005719:gamma-Globulins / Q000378:metabolism
D001798:Blood Proteins; D007106:Immune Sera; D005719:gamma-Globulins; D000641:Ammonia; D005337:Fibrin; D005176:Factor XIII; D013300:Streptokinase; D005341:Fibrinolysin; D011700:Putrescine